Thursday, October 15, 2020

Remdesivir Didn't Cut Hospital Stay Or Mortality In Covid Patients: WHO

Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

ESOP Jackpot: SBI Funds IPO Unlocks Massive Wealth; 13 Employees Hit Crorepati-Mark

SBI Funds Management's stock market debut has turned years of employee stock ownership into substantial wealth, with 13 employees holdin...